ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,005,000 | +133.7% | 618,658 | +710.6% | 0.02% | +128.6% |
| Q4 2021 | $2,142,000 | -54.4% | 76,324 | -44.8% | 0.01% | -65.0% |
| Q3 2021 | $4,699,000 | +194.6% | 138,256 | +254.2% | 0.02% | +150.0% |
| Q2 2021 | $1,595,000 | -46.6% | 39,034 | -22.7% | 0.01% | -52.9% |
| Q4 2020 | $2,987,000 | -66.4% | 50,521 | -72.3% | 0.02% | -73.8% |
| Q3 2020 | $8,881,000 | +778.4% | 182,634 | +773.7% | 0.06% | +622.2% |
| Q2 2020 | $1,011,000 | -92.0% | 20,903 | -95.1% | 0.01% | -88.0% |
| Q4 2019 | $12,689,000 | – | 424,087 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |